drugset / Trial / NCT00507949

Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight

NCT00507949

Phase 2 Completed 40 enrolled Rottapharm Spain
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to study the effect of megestrol acetate in the gain of body weight in patients with severe Chronic obstructive pulmonary disease in order to improve the survival of the patients.

Timeline

Start
2006-10
Primary completion
2009-04
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified 160 mg